Yann T.
- Country
- France
- Department
- Digestive Oncology
Research Overview
- Multiparametric Dynamic Whole-Body 68Ga-PSMA PET Imaging for Recurrence Detection in Hepatocellular Carcinoma: HIMIKO Study
- Phase 1b Study of NP137 with Atezolizumab-Bevacizumab in First-Line Treatment of Unresectable Hepatocellular Carcinoma
- Evaluation of 89Zirconium-labelled Girentuximab PET-CT Imaging in Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, and Gastroenteropancreatic Neuroendocrine Neoplasms
Data & Insights
Has run more than one trial at 289 of 551 partner sites.
Specializations
Gastrointestinal Oncology
This investigator specializes in various types of gastrointestinal cancers, with particular focus on colorectal cancer treatment approaches. Their research encompasses both early-stage and metastatic disease management.
- Colon Cancer Management
- Metastatic Colorectal Cancer
- Gastroesophageal Cancer
Their work includes evaluation of novel therapeutic combinations and personalized treatment approaches for gastrointestinal malignancies.
Hepatobiliary Oncology
The investigator has extensive experience in treating liver and biliary tract cancers. Their research focuses on innovative approaches for managing hepatocellular carcinoma and advanced biliary cancers.
- Hepatocellular Carcinoma
- Cholangiocarcinoma
- Biliary Tract Cancer
Their work includes evaluation of immunotherapy combinations and targeted treatments for hepatobiliary malignancies.
Precision Oncology
The investigator focuses on personalized medicine approaches in gastrointestinal cancers, including research on molecular targeted therapies and biomarker-driven treatment selection.
- Biomarker-Based Treatment
- Immunotherapy Applications
- Targeted Therapeutic Approaches
Their research includes evaluation of novel drug combinations and therapeutic monitoring strategies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.